Results 141 to 150 of about 3,006,184 (303)
Case Reports in Hematology, 2013 Myeloproliferative disorders are variable disorders, based on the genetic abnormality present and the cell line progenitors that are affected. In this case, we discuss a novel gene translocation in the subset of PDGFRB mutations, first seen with ...
Joel D. Provenzano, J. Phillip Kuebler
doaj +1 more source
Covert Brain Infarcts in Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders. [PDF]
J Clin Med, 2021 Kuznetsova PI +7 more
europepmc +1 more source
Haematalogical investigations in children [PDF]
, 2009 The haematology laboratory is able to perform a number of tests to help establish the cause of illness in children. The full blood count (FBC, also known as a complete blood count, CBC) is one of the most basic blood tests performed on children ...
Chalmers, E.A., Halsey, C.
core
Transient myeloproliferative disorder in children with
, 2012 Alan S. Gamis, Franklin O. Smith
openalex +1 more source
Cancer Reports, Volume 9, Issue 1, January 2026.ABSTRACT Background Hematopoietic stem cell transplantation (HSCT) is associated with significant morbidity and mortality. Frailty further increases these risks in recipients of HSCT. This systematic review analyzes the extent of frailty in patients with hematologic malignancies and patients undergoing HSCT, and explores the associations between ...
Marit Bakken +4 more
wiley +1 more source
Clinical Pharmacology &Therapeutics, Volume 119, Issue 1, Page 219-227, January 2026.Pegbing® (peginterferon alfa‐2b), a pegylated interferon‐alpha, is approved for the treatment of chronic hepatitis B (CHB) and C. One of its adverse effects is platelet (PLT) suppression. It is currently being repurposed for the treatment of essential thrombocythemia (ET), a rare myeloproliferative disorder characterized by abnormally elevated PLT ...
Weizhe Jian +7 more
wiley +1 more source
Molecular mechanisms in haematological malignancies [PDF]
, 2009 Haematopoiesis requires the constant production of large numbers of peripheral blood cells. This process is under tight control of transcription factor networks as well as cytokines, growth factors and hormones.
Avellino, Roberto +2 more
core
Myelodysplastic/myeloproliferative disorders
Haematologica, 2008 Luca Malcovati, Mario Cazzola
doaj +1 more source
Ischemic Stroke in a Young Man: Unraveling the Domain of Myeloproliferative Disorders. [PDF]
Cureus, 2021 Hamid MAB, Sehbai AS, Tariq S.
europepmc +1 more source